CASE STUDY
RNA-Based Therapies
Leverage customized bioanalytical approaches and efficient testing
Develop, test, and launch your RNA therapeutics with an all-inclusive approach that pairs scientific experts with a premier suite of bioanalytical platforms in state-of-the-art labs.
When a complex ADA assay failed at two prior CROs, the sponsor turned to BioAgilytix for help. See how we applied a novel approach to overcome target interference challenges on a tight deadline.
What You'll Learn:
- How BioAgilytix conducted the GCP study evaluating the drug for multiple indications.
- An in-depth overview of the innovative solution BioAgilytix created to overcome target interference challenges caused by dimerization.
- How the assay got back on track, and how this same solution can be applied to other studies, such as oncological programs.